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Abstract
Induction of histone acetylation in the nucleus accumbens (NAc), a key brain reward region,
promotes cocaine-induced alterations in gene expression. Histone deacetylases (HDACs) tightly
regulate the acetylation of histone tails, but little is known about the functional specificity of
different HDAC isoforms in the development and maintenance of cocaine-induced plasticity, and
prior studies of HDAC inhibitors report conflicting effects on cocaine-elicited behavioral
adaptations. Here, we demonstrate that specific and prolonged blockade of HDAC1 in NAc of
mice increased global levels of histone acetylation, but also induced repressive histone
methylation and antagonized cocaine-induced changes in behavior, an effect mediated in part via a
chromatin-mediated suppression of GABAA receptor subunit expression and inhibitory tone on
NAc neurons. Our findings suggest a novel mechanism by which prolonged and selective HDAC
inhibition can alter behavioral and molecular adaptations to cocaine and inform the development
of novel therapeutics for cocaine addiction.
Drug addiction is a chronic, debilitating psychiatric disorder characterized by high rates of
relapse. Recent studies suggest that post-translational modifications (PTMs) of histones in
nucleus accumbens (NAc), an important neural substrate for the addicting actions of drugs
of abuse, mediate long-lasting transcriptional and behavioral changes in response to cocaine
or other psychostimulants. For example, repeated psychostimulant administration increases
global levels of histone acetylation and decreases global levels of histone methylation
(which are normally associated with gene activation and repression, respectively) in NAc1–8.
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tHistone deacetylases (HDACs) are a family of enzymes capable of repressing gene
expression by removing acetyl groups from histone substrates9. Studies investigating the
effects of pan-HDAC inhibition on psychostimulant-induced behavioral plasticity have
yielded conflicting results, with some studies reporting that systemic or intra-NAc HDAC
inhibition enhances the behavioral effects of cocaine or amphetamine, and other studies
reporting changes in the opposite direction1,3–5,10–15. These discrepant findings suggest
layers of complexity that have not been adequately considered to date, which might include
different affinities of various HDAC inhibitors for different HDAC isoforms, highly specific
biological actions of different HDAC isoforms in regulating psychostimulant responses, and
time-dependent effects of HDAC inhibition in brain.
We addressed these possibilities in the present study in several ways. While previous work
has targeted a combination of Class I and II HDACs, Class III HDACs, or specific Class II
HDAC isoforms1,3–5,10–16, no study to date has systematically examined the role of nuclear-
specific Class I HDAC isoforms in the behavioral effects of drugs of abuse. We thus
induced local knockouts of HDAC1, 2, or 3 in NAc of adult floxed mice via viral expression
of Cre recombinase in this brain region, and found that only prolonged knockdown of
HDAC1 significantly suppressed cocaine-induced behavioral plasticity. While acute HDAC
inhibition enhances the behavioral effects of cocaine or amphetamine1,3,4,13,14, studies
suggest that more chronic regimens block psychostimulant-induced plasticity3,5,11,12. We
found that continuous infusion of the selective pharmacological HDAC inhibitor, N-(2-
aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) aminomethyl]benzamide (MS-275),
directly into NAc over a broad time course attenuated cocaine’s behavioral effects and
triggered other chromatin modifications in the NAc known to oppose cocaine-induced
plasticity. We show that prolonged HDAC inhibition paired with repeated cocaine
selectively induced a form of repressive histone methylation, dimethylation of Lys9 of
histone H3 (H3K9me2), in NAc, which, through the repression of GABAA receptor subunits
and inhibitory tone on NAc medium spiny neurons, contributed to blockade of cocaine-
induced plasticity. Together, these findings demonstrate cross talk among different types of
histone modifications in the adult brain and identify a novel molecular mechanism that
controls an individual’s sensitivity to psychostimulant exposure.
RESULTS
Regulation of Cocaine’s Behavioral Effects by HDAC1 in NAc
Most HDAC activity is catalyzed by Class I HDACs. To investigate the role of each of the
three main Class I HDACs most highly expressed in brain, HDACs 1-317, in cocaine action,
we engineered selective knockdowns of these enzymes from NAc by injecting a viral vector
expressing Cre into this brain region of adult mice homozygous for floxed alleles of each
enzyme isoform18,19 (Supplementary Fig. 1). We then tested the animals in a cocaine
locomotor sensitization paradigm, a widely used model of cocaine-induced behavioral
plasticity20,21. We found that the local knockdown of HDAC1 significantly reduced cocaine
locomotor sensitization, but had no effect on responses to initial cocaine doses (Fig. 1a). In
contrast, local knockdown of HDAC2 or HDAC3 had no effect on cocaine-induced
behaviors (Fig. 1c and e). Together, these findings establish a specific role for HDAC1,
compared with HDACs 2 and 3, in NAc in mediating behavioral responses to cocaine.
Selective knockdown of each of the three HDAC isoforms was confirmed by qPCR (Fig. 1b,
d, f). Interestingly, these knockdowns influenced the expression of other HDACs in NAc.
Local knockdown of HDAC1 decreased expression of HDAC2 and SIRT1 (a Class III
HDAC) and increased expression of HDAC5 (a Class II HDAC); both SIRT1 and HDAC5
have previously been implicated in cocaine’s behavioral effects5,16. In contrast, knockdown
of HDACs 2 or 3 led to compensatory increases in other Class I and II HDACs.
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tWe next tested whether direct infusion of the selective HDAC inhibitor, MS-275, had
similar effects. While MS-275 targets all three major Class I HDACs, HDACs 1-3, it
exhibits by far the highest in vitro affinity for HDAC1: EC50 (nM) = 181±62 (HDAC1),
1155±134 (HDAC2), and 2311±803 (HDAC3)22. In vivo selectivity of MS-275 has not
been examined. Mice were implanted with osmotic minipumps for continuous and direct
infusion of MS-275 into NAc. Five days after surgery, mice were subjected to our cocaine
locomotor sensitization paradigm (10 mg/kg). Similar to local knockdown of HDAC1,
chronic infusion of MS-275 into the NAc blocked cocaine-induced locomotor sensitization
with no effect on baseline mobility or responses to initial cocaine doses (Fig. 2a).
HDAC Regulation of Repressive Histone Methylation in NAc
Repeated cocaine administration has been shown to induce a global increase in histone
acetylation and a global decrease in repressive H3K9 methylation in NAc, both of which
promote transcriptional activation and behavioral responses to cocaine1,2,5,6,23. To validate
MS-275’s pharmacological activity, and to probe its effects on several types of cocaine-
regulated histone PTMs, we quantified levels of acetylated and methylated forms of H3 in
the NAc under the site of MS-275 infusion 24 hours after repeated cocaine (12 days of
continuous MS-275, 7 daily doses of cocaine 20 mg/kg). As shown previously24, intra-NAc
infusion of MS-275 increased global levels of acetylated H3 at Lys14 (H3K14ac) (Fig. 2b)
and repeated cocaine increased global levels of acetylated H3 at Lys9 (H3K9ac) (Fig. 2c).
Neither treatment altered total protein levels of H3 (Fig. 2b). To date, virtually nothing is
known about the catalytic selectivity of HDAC1 or other HDACs for various H3 acetylation
sites (e.g., K9 vs. K14); the apparent different effects of cocaine and MS-275 on H3K14 and
K9 acetylation might relate to the surrounding chromatin landscape, as K14’s neighboring
amino acids, unlike those of K9, are not modified. While MS-275 treatment alone did not
alter levels of either the repressive euchromatic mark H3K9me2 or the heterochromatic
trimethylation of H3 at Lys9 (H3K9me3), both were elevated when MS-275 was paired with
repeated cocaine (Fig. 2d and Supplementary Fig. 2a). We did not see a global decrease in
either of these marks following repeated cocaine alone, as we have published previously6,23.
However, this prior work was performed on non-operated (surgery-naïve) mice, and we
found that the use of cannulae and intra-NAc infusions alone increased global H3K9me2
levels in NAc (Supplementary Fig. 2b), which may have complicated our ability to detect
cocaine-induced decreases. Given that these measures are taken on a global scale, the
absence of a cocaine-induced decrease in global H3K9me2 does not preclude altered
targeting of this mark to specific gene promoters in response to cocaine. The effect of intra-
NAc infusion of MS-275 on histone PTMs in this brain region was specific to modifications
normally altered by repeated cocaine. Thus, neither repeated cocaine administration nor
MS-275 treatment produced changes in global levels of a major activating form of histone
methylation, H3 Lys4 trimethylation (H3K4me3), or of another repressive histone
methylation, H3 Lys27 trimethylation (H3K27me3) (Supplementary Fig. 2c and d).
In contrast to the effects seen with prolonged and continuous infusion of MS-275 into the
NAc, acute infusions just prior to daily cocaine treatment had no significant effect on
locomotor activity or sensitization (Supplementary Fig. 3a), indicating that chronic
knockdown or blockade of HDAC1 is required for attenuation of cocaine’s behavioral
effects. Furthermore, while acute MS-275 paired with cocaine treatment increased global
levels of H3K9ac, global levels of H3K9me2 remained unchanged (Supplementary Fig. 3b
and c), suggesting that the increase in H3K9me2 following chronic MS-275 treatment is
important for blocking sensitized locomotor responses to cocaine. Together, these findings
highlight a striking chromatin signature that occurs only in the combined presence of
chronic HDAC inhibition by MS-275 plus repeated exposure to cocaine.
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tTo gain insight into the mechanism underlying the selective increase in H3K9me2 and
H3K9me3 in NAc in response to local infusion of MS-275 plus repeated cocaine, we next
profiled lysine methyltransferases (KMTs) known to catalyze these repressive histone
marks: G9a, G9a-like protein (GLP), and suppressor of variegation 3–9 homolog 1
(SUV39H1). As previously shown6, 24 hours after repeated cocaine exposure, G9a
expression was significantly downregulated in NAc, with no effect seen on GLP or
SUV39H1 (Fig 2e). However, in striking contrast, expression of both G9a and SUV39H1
was significantly elevated in NAc of mice receiving MS-275 plus repeated cocaine (Fig. 2e),
consistent with the increased global levels of H3K9me2 and H3K9me3 seen uniquely under
these conditions. Given that MS-275 plus repeated cocaine increased global levels of AcH3,
we hypothesized that transcriptional activation of G9a and SUV39H1 following MS-275
treatment with repeated cocaine might be mediated through targeted binding of AcH3 at the
promoters of these KMTs. Using quantitative chromatin immunoprecipitation (qChIP) with
an antibody to H3K9ac, as we wanted to examine a promoter-enriched AcH3 mark24, we
found a significant increase in H3K9ac binding at the promoters of all three H3K9 KMTs,
G9a, GLP, and SUV39H1, following chronic MS-275 treatment with repeated cocaine (Fig.
2f). These data thus reveal a novel interplay between activating and repressive chromatin
remodeling: in the context of MS-275 mediated hyperacetylation, repeated exposure to
cocaine induces a targeted increase in repressive histone methylation that may serve to
dampen hyperactive patterns of gene expression.
To understand how HDAC1 might play a unique role in mediating cocaine-induced
decreases in H3K9 KMT gene expression, we used qChIP to probe the binding of the three
main Class I HDAC isoforms expressed in NAc, HDACs 1, 2 and 3, to KMT gene
promoters in NAc 4 hours after repeated cocaine. We found a significant increase in
HDAC1 binding at the promoters of both G9a and GLP (Fig 3a), but unaltered binding of
both HDACs 2 and 3 at these same promoters (Fig 3b and c). A peptide competition assay
with western blotting revealed that the antibodies used for this qChIP experiment are
specific for their respective targets (data not shown). These data suggest that repeated
cocaine induces the selective binding of HDAC1 to the G9a and GLP promoters, associated
with their repression, and provide one mechanism by which HDAC1 uniquely regulates
H3K9 KMT gene expression in response to repeated cocaine.
GABAergic Targets For MS-275-Cocaine Action
Since cocaine-induced decreases in repressive H3K9me2 in NAc are an important mediator
of behavioral responses to cocaine6, we hypothesized that the induction of H3K9me2
following MS-275 treatment with repeated cocaine observed here might be one key
mechanism by which chronic MS-275 administration blocks cocaine-regulated behavioral
sensitization. To identify possible gene targets for MS-275-induced transcriptional
repression, we profiled gene families known to be upregulated by cocaine and important for
cocaine-induced behavioral plasticity. Previous genome-wide promoter analyses using ChIP
coupled to promoter microarrays (ChIP-chip) identify several GABAA receptor subunits as
targets for increased transcription factor binding following repeated cocaine5. More recent
studies demonstrate cocaine-induced increases in the frequency of GABAA receptor-
mediated miniature inhibitory post-synaptic currents (mIPSCs) in striatonigral medium
spiny neurons in whole striatum and a requirement for α2 subunit-containing GABAA
receptors for the induction of behavioral sensitization to cocaine25,26. We therefore focused
on regulation of GABAA receptor subunits in our experimental paradigm.
We found that repeated cocaine significantly induced expression of multiple GABAA
receptor subunit genes in NAc and that cocaine-mediated increases in GABAA-α1, -α3, and
-β2 subunit genes (GABRA1, GABRA2 and GABRB2) were blocked by chronic intra-NAc
MS-275 infusion (Fig. 4a). MS-275infusion by itself caused an induction in GABAA
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treceptor subunit gene expression similar to that of cocaine alone, again demonstrating a
unique interaction upon combined exposure to MS-275 plus cocaine. We then probed
GABAA-α1 to verify whether its altered pattern in gene expression occurred at the protein
level. Indeed, GABAA-α1 protein levels displayed qualitatively similar patterns of
expression across treatment conditions (Supplementary Fig. 4a). These data suggest that
GABAA signaling in NAc may be an important mediator of cocaine-induced locomotor
activation. We therefore infused bicuculline, a competitive GABAA receptor antagonist, into
NAc and tested animals in the cocaine locomotor sensitization paradigm. We found that
daily infusion of bicuculline blocked the locomotor-activating effects of cocaine
(Supplementary Fig. 4b).
To test whether the transcriptional changes in GABAA receptor subunits correlated with
altered binding of acetylated and methylated H3 at specific gene promoters, we performed
qChIP with antibodies to H3K9ac or H3K9me2. We found that, while MS-275 treatment
with repeated cocaine caused a significant increase in H3K9ac binding at GABAA subunit
gene promoters, there was a much more prominent increase in repressive H3K9me2
enrichment, suggesting a reversal of cocaine-induced transcriptional de-repression with
MS-275 (Fig. 4b and c). We further found that repeated cocaine administration decreased
H3K9me2 binding at many GABAA subunit gene promoters in NAc, consistent with
cocaine’s known suppression of this mark in this brain region and with the cocaine-induced
patterns of GABAA subunit gene activation reported here (Fig. 4c).
To determine whether the reversal of cocaine-mediated increases in GABAA receptor
subunit expression by MS-275 is functional, we recorded spontaneous inhibitory
postsynaptic currents (IPSCs) from medium spiny neurons in the NAc shell of acute brain
slices prepared 12 days after minipump implantation and 24 hours after repeated cocaine or
saline. We found no difference in the amplitude of these events between the four conditions
(vehicle + saline, vehicle + cocaine, MS-275 + saline, and MS-275 + cocaine; Fig. 4d).
However, spontaneous IPSC frequency was significantly increased in animals receiving
either cocaine or MS-275 infusions alone, and this increase was completely reversed in
animals exposed to the two treatments in combination. The lack of change in amplitude
coupled with an alteration in frequency suggests that cocaine or MS-275 induce an increase
in the number of functional inhibitory synapses, without affecting individual synaptic
strength, consistent with previous findings25.
DISCUSSION
Our results provide the first evidence for a selective role of the nuclear specific Class I
HDAC, HDAC1, in mediating cocaine-induced behavioral plasticity and suggest a novel
interplay among activating and repressive histone PTMs in the transcriptional regulation of
cocaine-induced molecular adaptations. We show that local knockout of HDAC1, as well as
chronic and continuous infusion of MS-275, a pharmacological inhibitor highly selective in
vitro for HDAC1, in NAc suppressed cocaine-induced locomotor sensitization. This effect
was not seen with local knockout of other Class I isoforms, HDACs 2 and 3. Knockout of
these different HDACs resulted in distinct patterns of altered expression of other HDACs,
but only knockdown of HDAC1 affected expression of isoforms previously implicated in
behavioral responses to cocaine. We further show that both repeated cocaine and chronic
HDAC inhibition alone increased global levels of activating histone acetylation in the NAc
but that, in combination, these treatments induced repressive histone methylation through
H3K9ac binding at the promoters of specific KMTs and the subsequent induction of these
enzymes. Analysis of promoter occupancy 4 hours after repeated cocaine revealed the
selective association of HDAC1 with the G9a and GLP promoters in NAc, suggesting a
mechanism for HDAC1’s unique effects on repressive histone methylation and cocaine
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taction. Further studies are needed to understand the molecular steps by which HDAC1, but
not other Class I HDACs, is recruited to these KMT promoters. Finally, we identify GABAA
receptor subunits as functional targets for both cocaine-induced decreases in H3K9me2 and
cocaine plus MS-275 increases in this repressive methyl mark. Together, our findings
suggest a dynamic interplay among different types of histone modifications in the adult
brain, identify HDAC1 as a novel target for drug-induced plasticity, and reveal a role for,
and mechanism by which, GABAA receptors in NAc are altered to mediate physiological
changes important for the behavioral effects of cocaine.
Several studies to date have identified altered patterns of histone acetylation in NAc as
important mediators of psychostimulant-induced behavioral and molecular plasticity.
HDACs tightly regulate histone acetylation and both non-selective HDAC inhibition and
manipulations of specific Class II or III isoforms can alter psychostimulant-induced
adaptations1,3–5,10–16. Class I HDACs differ from other classes of HDACs in that they are
nuclear specific, demonstrating very little nuclear-cytoplasmic shuttling, and evidence
suggests highly specific biological actions of the different isoforms within this class27,28.
Recent reports have revealed that Class I HDAC isoforms 1–3 regulate memory and mediate
responses to antipsychotic drugs29–32, suggesting a potentially distinct role, as yet
unexplored, for such enzymes in drug addiction as well. The selective role for HDAC1
reported here may seem surprising given evidence of regulatory cross talk between HDACs
1-3, such that loss of HDAC1 in embryonic stem cells causes a compensatory upregulation
of HDACs 2 and 333. However, such a compensatory mechanism is thought to be
incomplete33. Moreover, we show a very different pattern of compensation in adult NAc.
Local knockdown of HDAC1 led to decreased HDAC2 and SIRT1 expression, which is in
agreement with previous findings that loss of HDAC1 leads to an overall reduction in total
HDAC activity in non-nervous tissues33. Interestingly, HDAC1 knockdown also caused an
upregulation in HDAC5 expression. Previous findings have implicated both SIRT1 and
HDAC5 in mediating behavioral responses to cocaine. SIRT1 is upregulated in NAc
following repeated exposure to cocaine and SIRT inhibition decreases behavioral responses
to the drug5. Conversely, nuclear levels of HDAC5 are downregulated in NAc by repeated
cocaine and loss of HDAC5 results in cocaine hypersensitivity16. While further work is
required to determine the extent to which such compensatory regulation of SIRT1 and
HDAC5 might contribute to the behavioral effects of HDAC1 knockdown, our observation
of selective HDAC1 binding to H3K9 KMTs suggests an important direct role for HDAC1.
As noted, evidence for distinct functions of Class I HDAC isoforms in the adult mouse brain
has been reported recently in a study comparing HDAC1 and 2 contributions to cognitive
processes. Although HDACs 1 and 2 form functional heterodimers and are often found in
the same protein complexes14, memory formation was impaired with overexpression of
HDAC2 but not HDAC1 in the hippocampus29. Our findings show an opposite dissociation
of function and implicate HDAC1 in NAc in cocaine-induced plasticity. These results
thereby provide new insight into the selective roles of Class I HDACs in the adult mouse
brain.
The effects of pharmacological inhibition of HDACs on psychostimulant-induced plasticity
appear to depend on the timecourse of HDAC inhibition. Studies employing co-
administration procedures in which inhibitors are given acutely, just prior to
psychostimulant administration, report heightened behavioral responses to the drug1,3,4,13,14.
In contrast, experimental paradigms like the one employed here, in which HDAC inhibitors
are administered more chronically, for several days prior to psychostimulant exposure, show
inhibited expression3 or decreased acquisition of behavioral adaptations to drug5,11,12. The
clustering of seemingly discrepant results based on experimental methodologies is
interesting in light of our present findings. Both HDAC inhibitors and psychostimulants
increase global levels of histone acetylation in NAc. Thus, when co-administered acutely,
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tthese drugs may have synergistic effects, leading to heightened transcriptional activation of
psychostimulant-regulated target genes. In contrast, when a psychostimulant is given in the
context of prolonged, HDAC inhibitor-induced hyperacetylation, homeostatic processes may
direct AcH3 binding to the promoters of genes (e.g., G9a) responsible for inducing
chromatin condensation and gene repression (e.g., via H3K9me2) in order to dampen
already heightened transcriptional activation. Our present findings thus demonstrate clear
cross talk among histone PTMs and suggest that decreased behavioral sensitivity to
psychostimulants following prolonged HDAC inhibition might be mediated through
decreased activity of HDAC1 at H3K9 KMT promoters and subsequent increases in
H3K9me2 and gene repression. The same complexity has been reported previously with
local knockdown of HDAC5 in the NAc16. While many genes were induced, just as many
were repressed, and among the induced genes were transcriptional repressors such as
SUV39H1.
Previous studies examining chromatin remodeling in NAc underlying drug-induced
behavioral plasticity have focused solely on histone PTMs known to occur on active,
euchromatic regions of the genome (e.g. H3K14ac, H3K9ac, H3K9me2, H3K4me3). More
recent evidence suggests that cocaine exposure additionally causes a de-repression of
previously silenced chromatin (heterochromatin) in NAc: repeated cocaine reduced global
levels of H3K9me3, a histone PTM that is associated specifically with silenced, non-coding
regions of the genome, which mediated a decrease in total heterochromatin levels in NAc23.
Our present findings, that chronic MS-275 plus repeated cocaine increase H3K9me3 and
expression of SUV39H1, the enzyme that catalyzes this modification, suggest that regulation
of non-coding regions of the genome may also be important for MS-275’s suppression of
cocaine-induced behavioral activation.
Numerous studies to date have implicated glutamatergic plasticity in the brain’s reward
circuitry in the development and maintenance of addictive-like behaviors. Studies have
shown that altered glutamate receptor subunit levels and altered glutamate transmission in
NAc are important molecular and physiological changes underlying the development of
cocaine-induced behavioral sensitization34–39. Further evidence suggests that glutamate
receptor subunits are targets for the transcription factors ΔFosB and phospho-CREB, and
that their genes display promoter hyperacetylation, providing one mechanism for the
sustained changes in glutamatergic transmission in NAc in response to repeated
cocaine5,14,39,40. More recent studies have begun to reveal a role for GABAA receptor
subunits in NAc in mediating cocaine-induced behavioral adaptations. Repeated cocaine
increases the frequency of GABAA receptor-mediated mIPSCs in striatonigral medium
spiny neurons, and α2 subunit-containing GABAA receptors are required for the induction
of cocaine behavioral sensitization25,26. Furthermore, ChIP-chip analyses have identified
several GABAA receptor subunits as direct, physiological targets for increased ΔFosB and
phospho-CREB binding following repeated cocaine5. Here, we provide further evidence for
GABAergic plasticity in NAc as a potential mediator of cocaine behavioral plasticity and
identify chromatin remodeling as a regulator of cocaine’s effect on GABAA receptor subunit
expression. Although GABAA receptor subunit expression, as well as inhibitory tone on
NAc medium spiny neurons, was increased by either cocaine or MS-275 alone, only the
cocaine-induced increase was associated with a behavioral phenotype. The absence of
enhanced locomotor activity following MS-275 treatment alone suggests that, although
increases in GABAA subunit expression and functional synaptic changes are necessary for
the expression of cocaine-induced locomotor activation, they are not sufficient. Several
studies to date have identified putative target genes for cocaine-induced promoter
hyperacetylation and transcriptional upregulation1,5,14. Only recently has cocaine-induced
decreases in repressive H3K9me2 promoter binding been linked to the transcriptional
upregulation of genes important in mediating behavioral adaptations to cocaine6,41. Our data
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to decreased binding of H3K9me2 at these gene promoters. Although combined treatment of
MS-275 and repeated cocaine did cause a significant increase in H3K9ac binding at GABAA
subunit gene promoters, we found a much more prominent increase in repressive H3K9me2
enrichment, suggesting that the normalization of GABAA subunit expression and inhibitory
tone on NAc medium spiny neurons under these conditions was mainly driven by a reversal
of cocaine-induced transcriptional de-repression.
The finding that MS-275 with repeated cocaine increased both H3ac and H3me2 on Lys9
residues at GABAA subunit gene promoters deserves further comment. The NAc is
composed primarily of two distinct subpopulations of medium spiny projection neurons,
those expressing dopamine D1- and those expressing dopamine D2-receptors, and these
different neuronal populations exhibit different molecular adaptations in response to
repeated cocaine42–44. In the present study, we did not distinguish between these different
neuronal subtypes, thus it is possible that the increases in H3ac and H3me2 at the same Lys
residue reported here are occurring in different neuronal populations. Future experiments are
required to address this and alternative possibilities.
The interaction between cocaine and MS-275 reported here is noteworthy. Either cocaine or
MS-275 treatment alone caused global increases in H3 acetylation and increases in GABAA
subunit gene expression, but when combined, these treatments caused increases in global
repressive H3K9me2, most likely driven by a loss of HDAC1 and a subsequent gain in H3ac
at H3K9 KMT promoters, that prevented cocaine-induced increases in GABAA subunit gene
expression and inhibitory tone in NAc (Supplementary Fig. 5). The results highlight a
unique mode of biological regulation that provides further insight into mechanisms of
chromatin regulation in the adult brain. Results of the present study also specifically inform
the mechanisms underlying the prolonged actions of HDAC inhibitors in NAc and broaden
current knowledge of molecular and chromatin endpoints for novel addiction treatments.
METHODS
Animals and treatments
Animals were housed in a colony room maintained at a constant temperature (23°C) on a 12
hour light/dark cycle (lights on from 0700 to 1900 hour) with ad libitum access to food and
water. Eight- to 10-week-old male C57BL6/J mice (Jackson Laboratory, Bar Harbor, ME,
USA) were used in all experiments unless stated otherwise. Animals were housed 5 per cage
and habituated in our facility 1 week before experimentation. Members of the same cage
were randomly assigned to different experimental groups for behavioral studies. All mouse
procedures were approved and performed in accordance with guidelines stipulated by the
Institutional Animal Care and Use Committee at Mount Sinai.
To induce focal deletion of specific Class I HDACs in NAc neurons, we used mutant mice
homozygous for a floxed HDAC1, 2 or 3 allele (backcrossed to C57BL/6J mice) which have
been described elsewhere18,19. Mice were sterotaxically-injected with herpes simplex virus
(HSV) vectors expressing GFP or Cre-GFP (HDAC1fl/fl and HDAC2fl/fl) or adeno-
associated virus (AAV) vectors expressing GFP or Cre-GFP (HDAC3fl/fl) in the NAc
between the age of 8 and 10 weeks. AAV vectors were used for HDAC3, as they were
required to obtain a degree of knockdown equivalent to that seen for HDACs 1 and 2. Both
vectors target neurons only and infect ~1 mm3 of brain6 (see Supplemental Fig. 1). The
efficiency of Cre-mediated recombination was quantified by quantitative PCR (qPCR) at the
end of behavioral testing. For experiments administering the pharmacological inhibitor N-
(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) aminomethyl]benzamide (MS-275,
100 μM; provided by Dr. Stephen Haggarty, the Broad Institute), mice were stereotaxically
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timplanted with subcutaneous Alzet mini-pumps (model 1002; Durect) fastened to bilateral
guide cannulae targeting the NAc. Twelve hours prior to implantation, mini-pumps were
activated to initiate continuous delivery (0.25 μl/hour over 14 days) of either vehicle (5
hydroxypropyl β-cyclodextrin; Trappsol, CTD) or drug. All mice were singly housed post-
surgery.
For Western blotting, qPCR, chromatin immunoprecipitation (ChIP), and electrophysiology,
mice receiving continuous delivery of either vehicle or MS-275 for 5 days were started on
daily injections of either saline (7 treatments saline, i.p.) or cocaine (7 treatments 20 mg/kg
cocaine-HCl, i.p.). Mice were used 24 hours after the final drug treatment and 12 days of
continuous vehicle or MS-275 infusion. For HDAC ChIPs, non-surgery mice received daily
injections of either saline (7 treatments saline, i.p.) or cocaine (7 treatments 20 mg/kg, i.p.)
and were used 4 hours after the final drug treatment. Note that we used a higher dose of
cocaine for these molecular studies compared with our behavioral testing, based on
established precedents in the literature where such higher doses are often required to detect
statistically significant findings.
Stereotaxic surgery
Mice anesthetized with a combination of ketamine (100 mg/kg) and xylazine (10 mg/kg)
were positioned in a small-animal stereotax and the cranial surface was exposed. Bilateral
infusions of virus (0.5 μl HSV or AAV) into the NAc were administered at a rate of 0.1 μl/
min using 33 gauge syringe needles positioned at a 10° angle (AP + 1.6; ML + 1.5; DV −
4.4 relative to Bregma). Mice receiving HSV or AAV infusions were given 6 and 20 days of
recovery following surgery, respectively. These timepoints were selected based on the onset
of maximal viral-mediated transgene expression for the two vectors and to mimic the
timecourse of MS-275 treatment prior to behavioral testing. For MS-275 infusions, two
mini-pumps were positioned subcutaneously on the mouse’s back. Two small cranial holes
were made above the NAc and bilateral cannulae (28 gauge stainless steel) were lowered at
a position of AP + 1.4; ML + 1.0; DV −4.0 from bregma. Mice were given 5 days recovery,
with continuous MS-275 or vehicle infusion, before beginning the cocaine locomotor assay
described below. All cannulae placements were verified at the time animals were killed
through visualization of the cannulae tracks; only animals with tracks terminating in the
NAc were included in the study (>90% of all animals tested).
For bicuculline (Tocris, Ellisville, MO) and acute MS-275 infusions, bilateral guide
cannulae (26-gauge, 5.0 mm length) were introduced 2.5 mm above the NAc at a position of
AP +1.6; ML + 1.0; DV − 3.4 from bregma. To prevent obstruction of the cannulae, at the
end of surgery, dummy cannulae were inserted into the guide cannulae. Mice were given 1
week recovery before beginning the cocaine locomotor assay described below. After
behavioral testing, injection sites were confirmed by direct visualization as noted above. In
the case of the acute MS-275 experiment 15-gauge NAc punches were collected for Western
blot analysis 30 minutes following the end behavioral testing.
Locomotor activity assay
Mice were injected with saline or cocaine (i.p.) at the same time each day and placed in
standard rat cages located inside a Photobeam Activity System (San Diego Instruments, San
Diego, CA). On day 0, mice were acclimated to the novel environment for 30 minutes and
then given a saline injection for baseline activity measures. On days 1–5 mice were given
injections of cocaine (10 mg/kg). Horizontal ambulations in the x and y plane were
measured for 30 minutes following all injections.
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tFor bicuculline and acute MS-275 experiments, daily drug (bicuculline dissolved in 0.9%
saline or MS-275, 100μM, dissolved in 5 hydroxypropyl β-cyclodextrin) or vehicle
infusions (10 ng/0.5 μl/side over 2.5 minutes) into the NAc were made through an inner
cannula (33-gauge) attached to a Hamilton syringe 15 minutes prior to behavioral testing.
The experimenter was not blinded for these experiments. Instances of faulty behavioral
tracking were removed from the analyses.
RNA isolation and qPCR
Bilateral 15-gauge NAc punches were homogenized in Trizol and processed according to
the manufacturer’s instructions. RNA was purified with RNAesy Micro columns (QIAGEN)
and spectroscopy confirmed that the RNA had 260/280 and 260/230 ratios >1.8. RNA was
reversed transcribed into cDNA using iScript cDNA synthesis (Bio-Rad). qPCR was
performed using ~2.5 ng of cDNA for each reaction plus primers and SYBR Green. Each
reaction was run in duplicate and analyzed following the ΔΔCt method as previously
described using glyceraldehyde- 3-phosphate dehydrogenase (GAPDH) as a normalization
control16. See Supplemental Table S1 for mRNA primer sequences. The experimenter was
not blinded for these experiments.
Western blot analysis
15-gauge NAc punches were homogenized in 30 μl of 1 M HEPES lysis buffer (1% SDS)
containing protease and phosphatase inhibitors using an ultrasonic processor. Protein
concentrations were determined using a DC protein assay and 10–20 μg samples of total
protein were electrophoresed on 18% Tris-HCl polyacrylamide gels. Proteins were
transferred to a nitrocellulose membrane, blocked for 1 hour in 5% BSA, and incubated
overnight at 4°C with either anti-AcH3K14 (Millipore, 1:1,000), anti-AcH3K9 (Abcam,
1:1,000), anti-H3K9me2 (Abcam, 1:500), anti-H3K9me3 (Millipore, 1:500), anti-H3K4me3
(Millipore, 1:500), anti-H3K27me3 (Millipore, 1:500), anti-GAPDH (Cell Signaling,
1:60,000) or anti-total histone H3 (Abcam, 1:5,000). Membranes were then incubated with
peroxidase-labeled secondary antibodies (1:15,000-1:60,000 depending on the primary
antibody used) and bands were visualized using SuperSignal West Dura substrate. Bands
were quantified with NIH Image J Software and normalized to GAPDH to control for equal
loading. The experimenter was not blinded for these experiments.
Chromatin immunoprecipitation (ChIP)
Fresh NAc punches were prepared for ChIP as previously described5,45 with minor
modifications. Briefly, 2 15-gauge NAc punches per animal (4 animals pooled per sample)
were collected, cross-linked with 1% formaldehyde and quenched with 2 M glycine before
freezing at −80°C. Prior to sample sonication, IgG magnetic beads (Invitrogen; sheep anti-
rabbit/mouse) were incubated with either anti-AcH3K9 (rabbit polyclonal ChIP grade,
Abcam), anti-H3K9me2 (mouse monoclonal ChIP grade, Abcam), anti-HDAC1 (mouse
monoclonal ChIP grade, Abcam), anti-HDAC2 (mouse monoclonal ChIP grade, Abcam) or
anti-HDAC3 (mouse monoclonal ChIP grade, Abcam) antibodies overnight at 4°C under
constant rotation in block solution. Tissue sonication and chromatin shearing were carried
out as previously described5. Average DNA fragment size in the range of 200–1,000 bps
was confirmed using Agilent 2100 Bioanalyzer. Following sonication, equal concentrations
of chromatin were transferred to new tubes and ~5% of the final products were saved to
serve as input controls. Following washing and resuspension of the antibody/bead
conjugates, antibody/bead mixtures (~7.0 μg antibody/sample) were added to each
chromatin sample and incubated for ~16 hours under constant rotation at 4°C. Samples were
further washed and reverse cross-linked at 65°C overnight and DNA purified using a PCR
purification kit (QIAGEN). Following DNA purification, samples were used for qPCR
analysis and normalized to their appropriate input controls as previously described5. Normal
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tmouse IgG immunoprecipitations were performed to control for appropriate enrichment of
signal amplification. See Supplemental Table S1 for promoter primer sequences. The
experimenter was not blinded for these experiments. The anti-HDAC1, -2, and -3 antibodies
used here for ChIP have been utilized in prior studies30,32,33. While we demonstrated the
specificity of each antibody with peptide blocking experiments and western blotting (see
main text), another important control lacking in the field is demonstrating selective
immunoprecipitation of each HDAC isoform by its respective antibody. Until such controls
become feasible technically, data for HDAC ChIPs must be viewed with some caution.
Electrophysiology
Coronal NAc slices (250 μm thick) were cut in ice-cold sucrose artificial CSF (ACSF) (in
mM): 254 sucrose, 3 KCl, 1.25 NaH2PO4, 10 D-glucose, 24 NaHCO3, 2 CaCl2, and 2
MgSO4, pH 7.35 (oxygenated with 95% O2 and 5% CO2, 295–305 mOsm). After a 1 h
recovery at 37°C in ACSF (254 mM sucrose replaced by 128 mM NaCl),
electrophysiological recordings were performed at 30–32°C in ACSF containing 1 mM
kynurenic acid to block EPSPs and 1.5 μM tetrodotoxin to block action potentials. Patch
pipettes (3–5 MΩ resistance) for whole-cell recordings were filled with an internal solution
containing the following (in mM): 130 cesium chloride, 10 HEPES, 10 phosphocreatine, 10
EGTA, 2 ATP-Mg, 0.5 GTP, and 1 QX-314 [2(triethylamino)-N-(2,6-dimethylphenyl)
acetamine] (a Na+ channel blocker), pH 7.4 (280–290 mOsm). The shell of the NAc was
identified under visual guidance using infrared differential interference contrast video
microscopy with a 40× water-immersion objective (Olympus BX51-WI). Whole-cell
voltage-clamp recordings were performed with a computer-controlled amplifier
(MultiClamp 700B), digitized (Digidata 1440), and acquired with Axoscope 10.1 (Molecular
Devices) at a sampling rate of 10 kHz. Only cells with resting membrane potential of −72 to
−82 mV and that displayed inward rectification were included for analysis. The frequency
and amplitude of spontaneous IPSCs were analyzed using Minianalysis software
(Synaptosoft). These experiments employed a blinding procedure.
Statistical analysis
Three-way ANOVAs were used to calculate statistics for locomotor activity of HDAC1fl/fl,
HDAC2fl/fl, HDAC3fl/fl, and MS-275 treated mice and their controls. Behavioral data for
these experiments were transformed to square root as in all of these datasets the means were
proportional to the variance as opposed to the standard deviation. One- and two-way
ANOVAs were performed to determine significance for all comparisons involving MS-275
and treatment, including Western blotting, qPCR, ChIP, and electrophysiology experiments.
Student’s t tests were performed to determine significance for all comparisons involving
HDAC chromatin immunoprecipitation with corrections for multiple comparisons. The
Grubbs’ test was employed when appropriate to identify outliers. All experiments were
carried out 1–3 times and in instances of repeated experiments data replication was
observed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors would like to thank Dr. Rachel Neve for viral vectors and Dr. Mark Baxter for statistical expertise. This
work was supported by grants from the National Institute on Drug Abuse and National Institute of Mental Health
(EJN) and the Canadian Institutes for Health Research (PJK: ref 90086).
Kennedy et al. Page 11
Nat Neurosci. Author manuscript; available in PMC 2013 October 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tReferences
1. Kumar A, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in
striatum. Neuron. 2005; 48:303–314. [PubMed: 16242410]
2. Levine AA, et al. CREB-binding protein controls response to cocaine by acetylating histones at the
fosB promoter in the mouse striatum. Proc Natl Acad Sci U S A. 2005; 102:19186–19191.
[PubMed: 16380431]
3. Kalda A, Heidmets LT, Shen HY, Zharkovsky A, Chen JF. Histone deacetylase inhibitors modulates
the induction and expression of amphetamine-induced behavioral sensitization partially through an
associated learning of the environment in mice. Behav Brain Res. 2007; 181:76–84. [PubMed:
17477979]
4. Shen HY, et al. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4
acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression
in the striatum and locomotor sensitization in mice. Neuroscience. 2008; 157:644–655. [PubMed:
18848971]
5. Renthal W, et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for
sirtuins. Neuron. 2009; 62:335–348. [PubMed: 19447090]
6. Maze I, et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity.
Science. 2010; 327:213–216. [PubMed: 20056891]
7. Malvaez M, Mhillaj E, Matheos DP, Palmery M, Wood MA. CBP in the Nucleus Accumbens
Regulates Cocaine-Induced Histone Acetylation and Is Critical for Cocaine-Associated Behaviors. J
Neurosci. 2011; 31:16941–16948. [PubMed: 22114264]
8. Levine A, et al. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine
prime gene expression by cocaine. Sci Transl Med. 2011; 3:107ra109.
9. Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128:693–705. [PubMed:
17320507]
10. Schroeder FA, et al. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of
class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate
cocaine-related behaviors. Neuropsychopharmacology. 2008; 33:2981–2992. [PubMed:
18288092]
11. Kim WY, Kim S, Kim JH. Chronic microinjection of valproic acid into the nucleus accumbens
attenuates amphetamine-induced locomotor activity. Neurosci Lett. 2008; 432:54–57. [PubMed:
18164815]
12. Romieu P, et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration
in rats. J Neurosci. 2008; 28:9342–9348. [PubMed: 18799668]
13. Sun J, et al. The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine- and
sucrose-maintained self-administration in rats. Neurosci Lett. 2008; 441:72–76. [PubMed:
18599214]
14. Wang L, et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of
CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement.
Neuropsychopharmacology. 2010; 35:913–928. [PubMed: 20010550]
15. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA. Modulation of chromatin
modification facilitates extinction of cocaine-induced conditioned place preference. Biol
Psychiatry. 2010; 67:36–43. [PubMed: 19765687]
16. Renthal W, et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic
emotional stimuli. Neuron. 2007; 56:517–529. [PubMed: 17988634]
17. Broide RS, et al. Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci. 2007;
31:47–58. [PubMed: 17416969]
18. Montgomery RL, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis,
growth, and contractility. Genes Dev. 2007; 21:1790–1802. [PubMed: 17639084]
19. Montgomery RL, et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in
mice. J Clin Invest. 2008; 118:3588–3597. [PubMed: 18830415]
Kennedy et al. Page 12
Nat Neurosci. Author manuscript; available in PMC 2013 October 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t20. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to
amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997; 25:192–216. [PubMed:
9403138]
21. Badiani A, Robinson TE. Drug-induced neurobehavioral plasticity: the role of environmental
context. Behav Pharmacol. 2004; 15:327–339. [PubMed: 15343056]
22. Khan N, et al. Determination of the class and isoform selectivity of small-molecule histone
deacetylase inhibitors. Biochem J. 2008; 409:581–589. [PubMed: 17868033]
23. Maze I, et al. Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in
nucleus accumbens. Proc Natl Acad Sci U S A. 2011; 108:3035–3040. [PubMed: 21300862]
24. Dion MF, et al. Dynamics of replication-independent histone turnover in budding yeast. Science.
2007; 315:1405–1408. [PubMed: 17347438]
25. Heiman M, et al. A translational profiling approach for the molecular characterization of CNS cell
types. Cell. 2008; 135:738–748. [PubMed: 19013281]
26. Dixon CI, et al. Cocaine effects on mouse incentive-learning and human addiction are linked to
alpha2 subunit-containing GABAA receptors. Proc Natl Acad Sci U S A. 2010; 107:2289–2294.
[PubMed: 20133874]
27. Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family:
functional implications of phylogenetic analysis. J Mol Biol. 2004; 338:17–31. [PubMed:
15050820]
28. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct HDAC(s) to treat
cognitive disorders. Trends Pharmacol Sci. 2010; 31:605–617. [PubMed: 20980063]
29. Guan JS, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature.
2009; 459:55–60. [PubMed: 19424149]
30. McQuown SC, et al. HDAC3 is a critical negative regulator of long-term memory formation. J
Neurosci. 2011; 31:764–774. [PubMed: 21228185]
31. Bahari-Javan S, et al. HDAC1 regulates fear extinction in mice. J Neurosci. 2012; 32:5062–5073.
[PubMed: 22496552]
32. Kurita M, et al. HDAC2 regulates atypical antipsychotic responses through the modulation of
mGlu2 promoter activity. Nat Neurosci. 2012; 15:1245–1254. [PubMed: 22864611]
33. Lagger G, et al. Essential function of histone deacetylase 1 in proliferation control and CDK
inhibitor repression. EMBO J. 2002; 21:2672–2681. [PubMed: 12032080]
34. White FJ, Hu XT, Zhang XF, Wolf ME. Repeated administration of cocaine or amphetamine alters
neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther.
1995; 273:445–454. [PubMed: 7714800]
35. Pierce RC, Bell K, Duffy P, Kalivas PW. Repeated cocaine augments excitatory amino acid
transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J
Neurosci. 1996; 16:1550–1560. [PubMed: 8778304]
36. Churchill L, Swanson CJ, Urbina M, Kalivas PW. Repeated cocaine alters glutamate receptor
subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral
sensitization. J Neurochem. 1999; 72:2397–2403. [PubMed: 10349849]
37. Boudreau AC, Wolf ME. Behavioral sensitization to cocaine is associated with increased AMPA
receptor surface expression in the nucleus accumbens. J Neurosci. 2005; 25:9144–9151. [PubMed:
16207873]
38. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci. 2007; 8:844–858.
[PubMed: 17948030]
39. Brown TE, et al. A silent synapse-based mechanism for cocaine-induced locomotor sensitization. J
Neurosci. 2011; 31:8163–8174. [PubMed: 21632938]
40. Kelz MB, et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to
cocaine. Nature. 1999; 401:272–276. [PubMed: 10499584]
41. Covington HE 3rd, et al. A role for repressive histone methylation in cocaine-induced vulnerability
to stress. Neuron. 2011; 71:656–670. [PubMed: 21867882]
Kennedy et al. Page 13
Nat Neurosci. Author manuscript; available in PMC 2013 October 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t42. Lee KW, et al. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-
containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci U S A. 2006;
103:3399–3404. [PubMed: 16492766]
43. Bertran-Gonzalez J, et al. Opposing patterns of signaling activation in dopamine D1 and D2
receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci. 2008;
28:5671–5685. [PubMed: 18509028]
44. Lobo MK, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine
reward. Science. 2010; 330:385–390. [PubMed: 20947769]
45. Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis
of protein location. Nat Protoc. 2006; 1:729–748. [PubMed: 17406303]
Kennedy et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2013 October 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 1.
HDAC1 in NAc regulates locomotor responses to cocaine. (a, c, e) Cocaine (coc, 10 mg/kg)
locomotor sensitization in floxed- (a) HDAC1 and (c) HDAC2 mice injected with HSV-
CreGFP or HSV-GFP, and (e) HDAC3 mice injected with AAV-CreGFP or AAV-GFP. All
data are presented as mean ± s.e.m. (a, c, e) A significant main effect (three-way ANOVA
on square-root transformed data) of day (a, F3,90 = 11.257, P < 0.0005; c, F3,36 = 26.040, P
< 0.0001; e, F3,57 = 19.479, P < 0.001) and drug (c, F1,12 = 24.238, P < 0.0001) and
significant interactions between day and virus (a, F3,90 = 3.007, P = 0.034) and day and drug
(a, F3,90 = 11.741, P < 0.0005; e, F3,57 = 11.976, P < 0.001) as well as a trend towards a day
by drug by virus interaction (a, F3,90 = 2.173, P = 0.097) were observed. *P < 0.04 and **P
< 0.001, Bonferroni post hoc tests. (b, d, f) qPCR validation of (b) HDAC1, (d) HDAC2,
and (f) HDAC3 knockdown and mRNA expression of other HDACs in the NAc of
HDAC1fl/fl, HDAC2fl/fl and HDAC3fl/fl mice. *P < 0.05, **P < 0.01 and ***P < 0.0001,
student’s t test. (For behavioral experiments: N = 4–6/group (saline condition); N = 6–11/
group (cocaine condition). For qPCR validation: N = 6–8/group).
Kennedy et al. Page 15
Nat Neurosci. Author manuscript; available in PMC 2013 October 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 2.
Chronic MS-275 infusion into NAc blocks locomotor responses to cocaine and alters
repressive histone methylation. (a) Cocaine (10 mg/kg) locomotor sensitization in animals
receiving continuous intra-NAc infusion of MS-275 or vehicle (Veh) (100 μM). A
significant main effect (three-way ANOVA on square-root transformed data followed by
Bonferroni post hoc tests) of day (F3,54 = 3.004, P = 0.037) and significant interactions
between day and drug (F3,54 = 4.578, P = 0.006) and day and treatment (F3,54 = 3.101, P =
0.034) were observed. Day by drug by treatment interaction (F3,54= 1.607, P = 0.19). (N = 5
or 6/group (vehicle treatment); N = 6 or 7/group (MS-275 treatment). (b–d) Global levels of
H3 acetylation and methylation in NAc after 12 days of continuous treatment with MS-275
(100 μM) and 24 hour after repeated cocaine (20 mg/kg, seven daily doses). All data
represented as normalized values to GAPDH (b) A significant main effect (two-way
ANOVA followed by Bonferroni post hoc tests) of treatment (H3K14ac, F1,22 = 23.20, ***P
< 0.001), (c) a main effect of drug (H3K9ac, F1,24 = 6.252, **P < 0.02), and (d) a significant
interaction between drug and treatment (H3K9me2, F1,18 = 15.23, P = 0.001) were observed
(N = 5–8/group). Full-length blots are presented in Supplemental Figure 6. (e and f) mRNA
expression of H3K9 KMTs and quantitative H3K9ac ChIP in NAc after 12 days of
continuous treatment with MS-275 (100 μM) and 24 hour after repeated cocaine (20 mg/kg).
(e) A significant interaction (two-way ANOVA followed by Bonferroni post hoc and
planned student’s t tests) between treatment and drug (G9a, F1,27 = 11.11, P = 0.0025;
SUV39H1- F1,27 = 12.82, P = 0.0013) was observed (N = 7 or 8/group). (f) A significant
effect (one-way ANOVA followed by Bonferroni post hoc tests) of MS-275 with repeated
cocaine on H3K9ac binding to H3K9 KMT promoters (G9a, F2,16 = 8.749, P = 0.0034;
GLP, F2,16 = 21.01, P < 0.0001; SUV39H1, F2,16 = 9.108, P = 0.0029 was observed (N = 5
or 6/group). #P = 0.14 (trend), *P < 0.05 and **P < 0.02, ***P < 0.001. All data are
represented as mean ± s.e.m.
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HDAC binding to KMT gene promoters after repeated cocaine. (a–c) Quantitative ChIP for
HDAC1, 2, and 3 in NAc from animals treated with repeated cocaine at 4 hours after the last
injection. Significance determined using Student’s t tests. (a) HDAC1 (GAPDH, t13 = 1.520,
P = 0.1524; G9a, t14 = 2.227, *P≤ 0.05; GLP, t14 = 2.090, *P≤ 0.05; SUV39H1, t12 = 1.735,
P = 0.108) (N = 7 or 8/group). (b) HDAC2 (GAPDH, t14 = 0.9857, P = 0.341), (G9a, t12
=0.2604, P = 0.799), (GLP, t11 = 0.3611, P = 0.7249), (SUV39H1, t14 = 1.343, P = 0.2006)
(N = 5–8/group). (c) HDAC3 (GAPDH, t12 = 1.061, P = 0.3098), (G9a, t12 = 1.624, P =
0.1303), (GLP, t12 = 0.4761, P = 0.6245), (SUV39H1, t12 = .1775, P = 0.8621) (N = 7/
group). All data are presented as percent input enrichment.
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Chronic MS-275 infusion prevents cocaine-induced changes in GABAA receptor subunit
expression and GABAergic tone in NAc. (a) mRNA expression of GABAA receptor
subunits (N = 5–8/group) in NAc after 12 days of continuous treatment with MS-275 (100
μM) and 24 hours after repeated cocaine (20 mg/kg). A significant interaction (two-way
ANOVA followed by Bonferonni post hoc tests) between treatment and drug for many
subunits was observed (GABRA1, F1,27 = 16.62, P = 0.004; GABRA2, F1,27 = 8.658, P =
0.0066; GABRA3, F1,26 = 21.83, P < 0.0001; GABRB2, F1,22 = 21.84, P < 0.0001;
GABRG2, F1,20 = 6.458, P = 0.0194). (b, c) Quantitative H3K9ac and H3K9me2 ChIP in
NAc from mice treated with repeated cocaine or chronic MS-275 infusion into NAc with
repeated cocaine at 24 hours. Data are presented as percent input enrichment (N = 5 or 6/
group). (b) A significant effect (one-way ANOVA followed by Bonferonni post hoc tests) of
MS-275 with repeated cocaine on H3K9ac binding at GABAA receptor subunit promoters
(GABRA1, F2,16 = 26.02, P < 0.0001; GABRA2, F2,16 = 11.37, P = 0.0012; GABRA3, F2,14
= 5.841, P = 0.0169; GABRB3, F2,16 = 14.39, P = 0.0004; Oct-4, F2,12 = 3.038, P = 0.0932)
was observed. (c) A significant difference (one-way ANOVA followed by Bonferonni post
hoc tests) in H3K9me2 binding at GABAA receptor subunit promoters (GABRA1, F2,16 =
4.902, P = 0.0243; GABRA2, F2,15 = 3.910, P = 0.0468; GABRA3, F2,16 = 10.77, P =
0.0015; GABRB3, F2,15 = 14.83, P = 0.0004; Oct-4, F2,13 = 1.365, P = 0.2954) was
observed. (d) IPSCs from NAc medium spiny neurons from mice treated with chronic saline
or cocaine, and exposed to intra-NAc infusion of vehicle or MS-275 (N = 5–8/group). A
significant interaction (two-way ANOVA followed by Bonferonni post hoc tests) between
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ttreatment and drug was observed for the frequency of spontaneous IPSCs (F1,23 = 14.43, P =
0.0009). *P < 0.05 and **P < 0.01. All data presented as mean ± s.e.m.
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